Format

Send to

Choose Destination
Medicine (Baltimore). 2017 Sep;96(35):e7974. doi: 10.1097/MD.0000000000007974.

Kallmann syndrome with a Tyr113His PROKR2 mutation.

Author information

1
aDepartment of Internal Medicine, Sanggye Paik Hospital, College of Medicine, Inaja University, Seoul bGreen Cross Genome, Yongin cCardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan dDepartment of Laboratory Medicine, Sanggye Paik Hospital, College of Medicine, Inje University, Seoul, Republic of Korea.

Abstract

RATIONAL:

Kallmann syndrome (KS) is a genetic gonadotropin-releasing hormone deficiency associated with hyposmia or anosmia and characterized by various modes of inheritance.

PATIENT CONCERNS:

A 16-year-old male did not reach puberty and was associated with hypogonadotropic hypogonadism and anosmia. His magnetic resonance imaging of brain revealed the absence of the olfactory bulb.

DIAGNOSIS:

His karyotype was 46 XY. Sanger sequencing of the KAL1 gene revealed no mutations. Diagnostic exome sequencing identified a prokineticin-receptor 2 (PROKR2) gene variant, c.337T > C (p.Tyr113His), previously reported to be a pathogenic mutation; we confirmed the presence of the mutation via Sanger sequencing of the coding exons of PROKR2. His apparently unaffected mother and sister, but not his father, were heterozygous for the PROKR2 Tyr113His mutation.

LESSONS:

This work advances our understanding of the role played by PROKR signaling and the mode of inheritance of the gene in patients with KS.

PMID:
28858133
PMCID:
PMC5585527
DOI:
10.1097/MD.0000000000007974
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center